Moderna is set to receive $590m in funding from the HHS to expedite the development of mRNA-based pandemic influenza vaccines ...
Aldevron, a global leader in the production of DNA, RNA and protein, has launched its latest innovation, Alchemyâ„¢ cell-free ...
The Company also announced that it is actively negotiating a supply agreement for GMP IVT template with a mRNA therapeutic developer. Separately, the Company reaffirmed its intention to complete ...